Zioptan
Zioptan is a preservative-free, topical prostaglandin analog ophthalmic solution. It lowers high pressure inside the eye by increasing the natural drainage of ocular fluid. This reduction in intraocular pressure helps prevent progressive optic nerve damage and subsequent vision loss associated with open-angle glaucoma and ocular hypertension.
Dosage by Body Weight
The recommended dosage is one drop in the conjunctival sac of the affected eye(s) once daily in the evening. Dosage should not exceed once daily, as more frequent administration may reduce the intraocular pressure-lowering effect.
- Body Weight
- Below 5 kg
- Dose
- Not established
- Frequency
- Not recommended
- Tracking Notes
- Safety and effectiveness in pediatric patients have not been established.
- Body Weight
- 5-7 kg
- Dose
- Not established
- Frequency
- Not recommended
- Tracking Notes
- Safety and effectiveness in pediatric patients have not been established.
- Body Weight
- 8-10 kg
- Dose
- Not established
- Frequency
- Not recommended
- Tracking Notes
- Safety and effectiveness in pediatric patients have not been established.
- Body Weight
- 11-15 kg
- Dose
- Not established
- Frequency
- Not recommended
- Tracking Notes
- Safety and effectiveness in pediatric patients have not been established.
- Body Weight
- 16-20 kg
- Dose
- Not established
- Frequency
- Not recommended
- Tracking Notes
- Safety and effectiveness in pediatric patients have not been established.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Not established | Not recommended | Safety and effectiveness in pediatric patients have not been established. |
| 5-7 kg | Not established | Not recommended | Safety and effectiveness in pediatric patients have not been established. |
| 8-10 kg | Not established | Not recommended | Safety and effectiveness in pediatric patients have not been established. |
| 11-15 kg | Not established | Not recommended | Safety and effectiveness in pediatric patients have not been established. |
| 16-20 kg | Not established | Not recommended | Safety and effectiveness in pediatric patients have not been established. |
Formulation
Purpose
Reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
Generic Name
TafluprostScheduled Drug
No. This medicine is generally not treated as a scheduled/prescription-only drug in common consumer references, but local rules may vary.